ZURICH, June 2 (Reuters) - Swiss drugmaker Roche said it was buying privately held U.S. gene-sequencing firm Genia Technologies for up to $350 million, securing access to a technology that should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback